Haima Therapeutics LLC
Cell-inspired therapies for bleeding and blood disorders.
Cleveland, United States · Founded 2018 · $4.0M raised
- Headquarters
- Cleveland, Ohio
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2G
- Website
- haimatherapeutics.com
- Total Funding
- $4.0M
- Last Round
- $4.0M GrantSep 2025
- Rounds
- 2
About
Haima Therapeutics is a pre-clinical stage biopharma company developing cell-inspired therapies for bleeding and blood-related diseases. Its lead technology, SynthoPlate, is a fully-synthetic nanoparticle-based hemostatic agent that mimics platelet function to control hemorrhagic bleeding after trauma, surgery, or in rare bleeding disorders. The company has received SBIR funding from DARPA, NIH, and NSF to advance SynthoPlate toward first-in-human clinical trials.
Summary
Haima Therapeutics LLC is a Biotech company based in Cleveland, United States, founded in 2018. It has raised $4.0M in total across 2 rounds, most recently a $4.0M Grant round in Sep 2025. Investors include Defense Advanced Research Projects Agency and National Institutes of Health.
Tech & App Stack
1 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sep 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...